Overexpression of adenylate cyclase‐associated protein 2 is a novel prognostic marker in malignant melanoma
Yohei Masugi(Keio University), Michiie Sakamoto(Keio University), Keiji Tanese(Toho University), Takeru Funakoshi(Keio University), Ken Yamazaki(Keio University), Katsura Emoto(Keio University), Mariko Mori, Kathryn Effendi(Keio University)
Cited by 23
Related Papers
Nivolumab for advanced melanoma: pretreatment prognostic factors and early outcome markers during therapy
|Oncotarget|2016|160
Diagnosis and Management of Basal Cell Carcinoma
|Current Treatment Options in Oncology|2019|153
G-Protein-Coupled Receptor GPR49 is Up-regulated in Basal Cell Carcinoma and Promotes Cell Proliferation and Tumor Formation
|American Journal Of Pathology|2008|141
Anti-PD1 checkpoint inhibitor therapy in acral melanoma: a multicenter study of 193 Japanese patients
|Annals of Oncology|2020|140